Table 3 Bivariate Analysis Association between Comorbidities and NAFLD
Variables | NAFLD, n (%) | Total | p value | PR | CI 95% | |
|---|---|---|---|---|---|---|
Yes | No | |||||
DM, n (%) | ||||||
 Yes | 85 (70.8) | 35 (29.2) | 120 (100) | 0.612 | 0.810 | 0.358–1.832 |
 No | 30 (75.0) | 10 (25.0) | 40 (100) |  |  |  |
Dyslipidemia, n (%) | ||||||
 Yes | 97 (75.2) | 32 (24.8) | 129 (100) | 0.057 | 2.189 | 0.966–4.959 |
 No | 18 (58.1) | 13 (41.9) | 31 (100) |  |  |  |
Obesity, n (%) | ||||||
 Yes | 82 (76.6) | 25 (23.4) | 107 (100) | 0.057 | 1.988 | 0.974–4.057 |
 No | 33 (62.3) | 20 (37.7) | 53 (100) |  |  |  |
Metabolic Syndrome, n (%) | ||||||
 Yes | 89 (73) | 33 (27) | 122 (100) | 0.588 | 1.245 | 0.564–2.748 |
 No | 26 (68.4) | 12 (31.6) | 38 (100) |  |  |  |
Central Obesity, n (%) | ||||||
 Yes | 109 (73.2) | 40 (26.8) | 149 (100) | 0.294 | 2.271 | 0.657–7.854 |
 No | 6 (54.5) | 5 (45.5) | 11 (100) |  |  |  |